Combination therapy with AT1-receptor blockers
نویسندگان
چکیده
منابع مشابه
AT1-receptor blockers
finding of elevated leptin levels in cardiac failure patients stage NYHA II or III is supported by Filippatos et al. and others. From their data, however, it appears that leptin levels tend to decrease in cachectic patients with more advanced stages of the disease, which has only recently been confirmed by others. This does not necessarily contradict our observations. The patients reported in o...
متن کاملAT1 receptor blockers for cognition decline after cardiac surgery?
AT1 Receptor Blockers for Cognition Decline After Cardiac Surgery? To the Editor: We read with interest the review article on stroke and encephalopathy after cardiac surgery1 and the related editorial.2 We agree that assessing these complications provides a unique clinical opportunity for evaluating preventive strategies because patients at higher risk can be identified before surgery. We would...
متن کاملCombination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure.
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers have different pharmacologic mechanisms for blocking the effect of the renin-angiotensin-aldosterone system on the cardiovascular system. Pharmacologically, the combination of these drug classes completely blocks the deleterious effect of angiotensin in patients with heart failure. However, clinical trials have not shown...
متن کاملAngiotensin receptor blockers: baseline therapy in hypertension?
The provocative editorial by Verma and Strauss in the BMJ 5 years ago stating that angiotensin receptor blockers (ARBs) ‘may increase myocardial infarction—and patients may need to be told’ caused a tempest in the teapot and led to extensive scrutiny of outcome data with this drug class. In 2007 the blood pressurelowering treatment trialists collaboration found that there were similar blood pre...
متن کاملCombination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease
Dual blockade of the renin-angiotensin system (RAS) with a combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the treatment of hypertension and proteinuria has been tested in several randomized trials among patients with chronic kidney disease (CKD). Although combination therapy reduces proteinuria and blood pressure, adequately powered studies evaluat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Human Hypertension
سال: 2002
ISSN: 0950-9240,1476-5527
DOI: 10.1038/sj.jhh.1001435